longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Resmed

RMD

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 21.02, below the reasonable range, cheaper than 90.54% of the time in the past 3 years, and the industry ranks 19/175, the industry Median -0.92.

21.02xP/E
$221.97Stock price
$10.56Earnings per share
21.02xP/E
Stock price$221.97Earnings per share$10.56

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
27.92x
Typical range
23.40x–31.57x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
MDTUSMedtronic
22.20x26.73%$116.11B
SYKUSStryker
28.30x53.09%$105.52B
BSXUSBoston Scientific
17.72x36.31%$65.10B
RMDUSResmed
21.02x11.93%$32.02B
GEHCUSGE HealthCare Tech
15.08x2.63%$29.93B
RYLPFUSKoninklijke Philips N.V.
17.79x--$23.01B
PHGUSKoninklijke Philips Elect
18.87x16.23%$24.41B
TRUMYUSTerumo
19.92x--$20.93B
STEUSSteris
25.29x17.10%$20.36B
ZBHUSZimmer Biomet
22.22x37.01%$17.93B
SNNUSSmith and Nephew
18.21x42.74%$11.57B
GMEDUSGlobus Medical Inc
18.85x6.02%$10.10B
PODDUSInsulet
25.76x76.42%$9.67B
SSMXYUSSysmex
28.28x--$7.15B
LIVNUSLivanova
22.93x189.82%$4.32B
TMDXUSTransMedics
20.13x71.90%$3.05B
INSPUSInspire Medical
15.26x100.86%$2.06B
LMATUSLemaitre Vascular
28.17x13.99%$1.85B
CNMDUSConmed
24.48x156.95%$1.38B
TCMDUSTactile
20.66x36.59%$513.75M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.